Samuel Kabwigu

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

Jared M. Baeten, Thesla Palanee‐Phillips, Nyaradzo Mgodi et al. · The Lancet HIV · 2021 · 111 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +16

Impact of Male Partner Involvement on Women’s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial

Sarah T. Roberts, Gonasagrie Nair, Jared M. Baeten et al. · AIDS and Behavior · 2019 · 47 citations · Full text

Medicine, Gynecology, Pharmacotherapy +13

Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy

Bonus Makanani, Jennifer E. Balkus, Yuqing Jiao et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2018 · 35 citations

Medicine, Maternal Health, Obstetrics +17

Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception

Jennifer E. Balkus, Thesla Palanee‐Phillips, Krishnaveni Reddy et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 18 citations

Medicine, Pharmacotherapy, Preventive Medicine +17

Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexposure Prophylaxis

Melanie R. Nicol, Prosperity Eneh, Rita Nakalega et al. · Clinical Infectious Diseases · 2019 · 17 citations · Full text

Public Health, Infectious Diseases, Pharmacokinetics +17